Summit Wealth & Retirement Planning’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
Summit Wealth & Retirement Planning's AQST Position: Q3 2026 in Review
Summit Wealth & Retirement Planning reduced its Aquestive Therapeutics (AQST) stake by 14% in Q3 2026, selling an estimated $22.2K and leaving 30,000 shares worth $139K. The position accounts for 0.03% of the portfolio, ranked #109.
Summit Wealth & Retirement Planning first reported a position in AQST in Q1 2025 and has held it in 7 quarters since. The position peaked at $146K in Q2 2026. 190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.
- Summit Wealth & Retirement Planning held 30,000 shares of Aquestive Therapeutics worth $139K as of Q3 2026.
- Summit Wealth & Retirement Planning sold 5,000 Aquestive Therapeutics shares in Q3 2026, an estimated $22.2K.
- Aquestive Therapeutics made up 0.03% of Summit Wealth & Retirement Planning's portfolio in Q3 2026, its #109 holding.
- Summit Wealth & Retirement Planning first reported a position in Aquestive Therapeutics in Q1 2025 and has held it in 7 quarters since.
- Summit Wealth & Retirement Planning's Aquestive Therapeutics position peaked at $146K in Q2 2026.
- 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.
Based on Summit Wealth & Retirement Planning's 13F filing for Q3 2026, filed 12 Nov 2026.